WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Up 118.2% in July

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw a significant growth in short interest during the month of July. As of July 15th, there was short interest totaling 255,103 shares, a growth of 118.2% from the June 30th total of 116,931 shares. Based on an average daily volume of 144,071 shares, the short-interest ratio is presently 1.8 days. Currently, 0.0% of the company’s stock are short sold.

WuXi Biologics (Cayman) Price Performance

Shares of WXXWY stock opened at $9.80 on Tuesday. The company’s fifty day simple moving average is $8.72 and its 200-day simple moving average is $9.09. WuXi Biologics has a 12 month low of $7.27 and a 12 month high of $11.21.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.